In addition, ERK pathway activation induced by RAS or RAF also engages in EMT, and ERK1/2 blockade inhibits EMT in lung cancer cells, which suggests that ERK1/2 functions as an EMT inducer [26]. This evidence concerns the gene MAPK1 and lung carcinoma.